MRAP | Melanocortin 2 receptor accessory protein | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
URB1 | URB1 ribosome biogenesis 1 homolog (S. cerevisiae) | Plasma proteins
| | | | | Expressed in all |
C21orf119 | Chromosome 21 open reading frame 119 | | | | | | Expressed in all |
EVA1C | Eva-1 homolog C (C. elegans) | Predicted membrane proteins
| | | | | Expressed in all |
TCP10L | T-complex 10-like | | | | | | Tissue enriched |
AP000275.65 | Uncharacterized protein | | | | | | Mixed |
C21orf59 | Chromosome 21 open reading frame 59 | Disease related genes
| | | | | Expressed in all |
SYNJ1 | Synaptojanin 1 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
PAXBP1 | PAX3 and PAX7 binding protein 1 | Plasma proteins
| | | | | Expressed in all |
C21orf62 | Chromosome 21 open reading frame 62 | Predicted secreted proteins
| | | | | Tissue enhanced |
OLIG2 | Oligodendrocyte lineage transcription factor 2 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
C21orf54 | Chromosome 21 open reading frame 54 | | | | | | Tissue enriched |
IFNAR2 | Interferon (alpha, beta and omega) receptor 2 | Cancer-related genes FDA approved drug targets Predicted membrane proteins
| | | | | Expressed in all |
IL10RB | Interleukin 10 receptor, beta | CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IFNAR1 | Interferon (alpha, beta and omega) receptor 1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IFNGR2 | Interferon gamma receptor 2 (interferon gamma transducer 1) | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
TMEM50B | Transmembrane protein 50B | Predicted membrane proteins
| | | | | Expressed in all |
DNAJC28 | DnaJ (Hsp40) homolog, subfamily C, member 28 | | | | | | Mixed |
GART | Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
SON | SON DNA binding protein | Plasma proteins Transporters
| | | | | Expressed in all |
DONSON | Downstream neighbor of SON | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
AP000304.12 | | | | | | | Not detected |
CRYZL1 | Crystallin, zeta (quinone reductase)-like 1 | | | | | | Expressed in all |
ITSN1 | Intersectin 1 (SH3 domain protein) | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP5O | ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit | Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
MRPS6 | Mitochondrial ribosomal protein S6 | Mitochondrial proteins Ribosomal proteins
| | | | | Expressed in all |
SLC5A3 | Solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC5A3 | Sodium/myo-inositol cotransporter | Predicted membrane proteins
| | | | | Tissue enhanced |
KCNE2 | Potassium voltage-gated channel, Isk-related family, member 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
SMIM11 | Small integral membrane protein 11 | Predicted membrane proteins
| | | | | Expressed in all |
C21orf140 | Chromosome 21 open reading frame 140 | | | | | | Mixed |
AP000322.53 | | Predicted membrane proteins
| | | | | Group enriched |
KCNE1 | Potassium voltage-gated channel, Isk-related family, member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
RCAN1 | Regulator of calcineurin 1 | | | | | | Expressed in all |
CLIC6 | Chloride intracellular channel 6 | Transporters
| | | | | Tissue enhanced |
RUNX1 | Runt-related transcription factor 1 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Mixed |
FKSG68 | | | | | | | Not detected |
SETD4 | SET domain containing 4 | | | | | | Expressed in all |
CBR1 | Carbonyl reductase 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
CBR3 | Carbonyl reductase 3 | Enzymes
| | | | | Mixed |
DOPEY2 | Dopey family member 2 | | | | | | Expressed in all |
MORC3 | MORC family CW-type zinc finger 3 | | | | | | Expressed in all |
CHAF1B | Chromatin assembly factor 1, subunit B (p60) | Plasma proteins
| | | | | Mixed |
SIM2 | Single-minded family bHLH transcription factor 2 | Transcription factors
| | | | | Tissue enhanced |
HLCS | Holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
RIPPLY3 | Ripply transcriptional repressor 3 | | | | | | Not detected |
PIGP | Phosphatidylinositol glycan anchor biosynthesis, class P | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
TTC3 | Tetratricopeptide repeat domain 3 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
DSCR3 | Down syndrome critical region gene 3 | Plasma proteins
| | | | | Expressed in all |
DYRK1A | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |